Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition
Open Access
- 29 October 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 38 (5) , 1402-1408
- https://doi.org/10.1016/s0735-1097(01)01562-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Bradykinin Stimulates Tissue Plasminogen Activator Release From Human Forearm Vasculature Through B 2 Receptor–Dependent, NO Synthase–Independent, and Cyclooxygenase-Independent PathwayCirculation, 2000
- Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in manCardiovascular Research, 2000
- CORONARY DISEASE: The pathophysiology of acute coronary syndromesHeart, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Bradykinin Stimulates Tissue Plasminogen Activator Release in Human VasculatureHypertension, 1999
- Vascular-Bed–Specific Hemostasis and Hypercoagulable StatesNew England Journal of Medicine, 1999
- Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculatureJournal of the American College of Cardiology, 1998
- Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.The Journal of Physiology, 1989
- Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasmaBlood, 1988
- Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.Circulation, 1985